JP2020059683A
|
|
Nerve growth factor promoting composition
|
JP2020059684A
|
|
Brain-derived neurotrophic factor promoting composition
|
JP2019182801A
|
|
Melanogenesis inhibitory composition, skin whitening composition, and expression inhibitory composition
|
JP2018177735A
|
|
Monoacylglycerol, antibacterial agent, and monoacylglycerol production method
|
JP2018135311A
|
|
Fgf21 expression promoting composition
|
JP2016150933A
|
|
Method for manufacturing evodiamine
|
JP2016065004A
|
|
Urokinase inhibitor and angiogenic inhibitor
|
JP2015077085A
|
|
Fermented food
|
JP2014227339A
|
|
Mycosporin-like amino acids, production method thereof, uv protecting agents and antioxidants
|
JP2014024813A
|
|
Autophagic cell death inducer
|
JP2014024814A
|
|
Anti-acne agent
|
JP2014024812A
|
|
Nitric oxide production inhibitor and anti-inflammatory drug
|
JP2014019668A
|
|
Hyaluronidase inhibitor
|
JP2013095694A
|
|
Carcinogenesis promotion inhibitor and method for producing the same
|
JP2012224576A
|
|
Isoprenoid compound, method for producing the same, and antioxidant
|
JP2012214426A
|
|
Organic compound, process for producing organic compound, and anti-helicobacter pylori agent
|
JP2011105656A
|
|
Uncoupling protein expression-inducing agent and improving agent of the cold
|
JP2010189304A
|
|
Immunoglobulin a production promoter
|
JP2009280523A
|
|
Skin beautifying agent
|
JP2009203168A
|
|
Composition for preventing infectious disease, and food and drink and feed comprising the same
|